TER Form 144: Mercedes Johnson plans $66K share sale on 8/5/25

Rhea-AI Filing Summary

Teradyne, Inc. (TER) filed a Form 144 indicating that shareholder Mercedes Johnson plans to sell up to 625 common shares through Fidelity Brokerage on or after 08/05/2025. At the latest reported market price, the sale would total roughly $66,250. The shares originated from a 05/09/2024 restricted-stock vesting transaction and were received as compensation.

Johnson has already sold 1,875 shares for $198,243.75 during the past three months. The proposed sale represents 0.0004 % of TER’s 159,073,532 shares outstanding, suggesting minimal dilution or trading-volume impact. No material adverse information was reported, and the signer affirms compliance with Rule 10b5-1 and other SEC requirements.

Positive

• Sale volume is immaterial: 625 shares equals only 0.0004 % of outstanding stock, limiting dilution or price pressure.
• Clear Rule 144 and 10b5-1 compliance signals strong governance and transparency.

Negative

• Continued insider selling (total 2,500 shares over three months) could be perceived as reduced insider confidence, albeit small scale.

Insights

Financial Analyst

TL;DR Small insider sale (625 shares) is immaterial to float; signals routine diversification, not strategic shift.

The filing discloses a prospective divestiture worth $66k versus TER’s multibillion-dollar market cap. Insider sales can raise eyebrows, but here the volume is negligible (0.0004 % of shares). Coupled with prior 1,875-share sales, total recent disposals remain de minimis. Because shares stem from vested compensation, this appears to be planned liquidity rather than a valuation call. I view the impact on valuation or sentiment as neutral; however, investors may monitor future filings for acceleration or larger blocks.

Corporate Governance Expert

TL;DR Filing shows compliance with Rule 144 and 10b5-1; governance processes appear intact.

Management’s adherence to disclosure rules, explicit affirmation of no undisclosed adverse info, and use of a reputable broker indicate a standard, well-governed transaction. The staggered sale schedule mitigates market impact and aligns with best practices for insiders monetizing equity compensation. No red flags regarding timing, aggregation limits, or undisclosed consideration are evident. Overall governance risk from this notice is low.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	625	66250.00	159073532	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2024	Restricted Stock Vesting	Issuer			625	05/09/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mercedes Johnson 600 Riverpark Drive, North Reading North Reading MA 01864	Common	07/30/2025	1875	198243.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Teradyne (TER) shares are being proposed for sale?

625 common shares are scheduled for sale under this Form 144.

What is the estimated value of the proposed sale?

At current pricing, the sale is valued at approximately $66,250.

When is the planned sale date for the TER shares?

The filing lists an approximate sale date of 08/05/2025.

What percentage of Teradyne’s outstanding shares does the sale represent?

Only about 0.0004 % of the 159,073,532 shares outstanding.

Has the seller disposed of TER shares recently?

Yes. 1,875 shares were sold on 07/30/2025 for $198,243.75.

Where will the shares be sold?

Through Fidelity Brokerage Services LLC on the NASDAQ exchange.